Fosdenopterin (WHO-11150; ALXN 1101; Precursor Z; BBP-870; Nulibry) is a synthetic cyclic pyranopterin monophosphate (cPMP) that has been approved in 2021 as a medication to reduce the risk of mortality in patients with molybdenum cofactor deficiency Type A, which is a rare genetic disease.

纯度：≥98%

CAS：150829-29-1